JP2005521663A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005521663A5 JP2005521663A5 JP2003563536A JP2003563536A JP2005521663A5 JP 2005521663 A5 JP2005521663 A5 JP 2005521663A5 JP 2003563536 A JP2003563536 A JP 2003563536A JP 2003563536 A JP2003563536 A JP 2003563536A JP 2005521663 A5 JP2005521663 A5 JP 2005521663A5
- Authority
- JP
- Japan
- Prior art keywords
- formoterol
- salt
- transmitted
- backscattered
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0200312A SE0200312D0 (sv) | 2002-02-01 | 2002-02-01 | Novel composition |
| PCT/SE2003/000156 WO2003063842A1 (en) | 2002-02-01 | 2003-01-29 | Composition for inhalation |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010041992A Division JP5259636B2 (ja) | 2002-02-01 | 2010-02-26 | 吸入用組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005521663A JP2005521663A (ja) | 2005-07-21 |
| JP2005521663A5 true JP2005521663A5 (https=) | 2006-02-16 |
Family
ID=20286853
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003563536A Withdrawn JP2005521663A (ja) | 2002-02-01 | 2003-01-29 | 吸入用組成物 |
| JP2010041992A Expired - Lifetime JP5259636B2 (ja) | 2002-02-01 | 2010-02-26 | 吸入用組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010041992A Expired - Lifetime JP5259636B2 (ja) | 2002-02-01 | 2010-02-26 | 吸入用組成物 |
Country Status (27)
| Country | Link |
|---|---|
| US (8) | US7759328B2 (https=) |
| EP (2) | EP1474117B1 (https=) |
| JP (2) | JP2005521663A (https=) |
| KR (2) | KR100947168B1 (https=) |
| CN (1) | CN1287774C (https=) |
| AT (2) | ATE463241T1 (https=) |
| AU (1) | AU2003206289B2 (https=) |
| BR (1) | BR0307193A (https=) |
| CA (1) | CA2474479C (https=) |
| CO (1) | CO5611098A2 (https=) |
| CY (2) | CY1109030T1 (https=) |
| DE (2) | DE60326320D1 (https=) |
| DK (2) | DK1474117T3 (https=) |
| ES (2) | ES2342509T3 (https=) |
| IL (1) | IL163160A (https=) |
| IS (2) | IS7360A (https=) |
| MX (1) | MXPA04007295A (https=) |
| NO (1) | NO337006B1 (https=) |
| NZ (1) | NZ534452A (https=) |
| PL (1) | PL211836B1 (https=) |
| PT (2) | PT1474117E (https=) |
| RU (1) | RU2301673C2 (https=) |
| SE (1) | SE0200312D0 (https=) |
| SI (2) | SI2036549T1 (https=) |
| UA (1) | UA79445C2 (https=) |
| WO (1) | WO2003063842A1 (https=) |
| ZA (1) | ZA200406086B (https=) |
Families Citing this family (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE0200312D0 (sv) | 2002-02-01 | 2002-02-01 | Astrazeneca Ab | Novel composition |
| US9084799B2 (en) | 2005-02-11 | 2015-07-21 | Pulmagen Therapeutics (Synergy) Limited | Inhaled combination therapy |
| ATE421325T1 (de) * | 2005-02-11 | 2009-02-15 | Argenta Discovery Ltd | Kombination von methylxanthinverbindungen und steroiden zur behandlung chronischer atemwegserkrankungen |
| DE102006053374A1 (de) * | 2006-02-09 | 2007-08-16 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Pharmazeutische Formulierung für Aerosole mit zwei oder mehr Wirkstoffen und mindestens einer oberflächenaktiven Substanz |
| GB0604141D0 (en) * | 2006-03-01 | 2006-04-12 | Arrow Int Ltd | Nebulizer formulation |
| GB0712454D0 (en) * | 2007-06-27 | 2007-08-08 | Generics Uk Ltd | Pharmaceutical compositions |
| EP2077132A1 (en) | 2008-01-02 | 2009-07-08 | Boehringer Ingelheim Pharma GmbH & Co. KG | Dispensing device, storage device and method for dispensing a formulation |
| US20130160761A1 (en) * | 2008-11-04 | 2013-06-27 | Cipla Limited | Pharmaceutical Aerosol Composition |
| NZ574666A (en) * | 2009-02-05 | 2009-04-30 | Nexus6 Ltd | A medicament inhaler holder that uses optical means to count and display the number of doses used |
| EP2414560B1 (de) | 2009-03-31 | 2013-10-23 | Boehringer Ingelheim International GmbH | Verfahren zur beschichtung einer oberfläche eines bauteils |
| JP5763053B2 (ja) | 2009-05-18 | 2015-08-12 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | アダプタ、吸入器具及びアトマイザ |
| US10016568B2 (en) | 2009-11-25 | 2018-07-10 | Boehringer Ingelheim International Gmbh | Nebulizer |
| BR112012012475B1 (pt) | 2009-11-25 | 2020-03-03 | Boehringer Ingelheim International Gmbh | Nebulizador |
| WO2011064163A1 (en) | 2009-11-25 | 2011-06-03 | Boehringer Ingelheim International Gmbh | Nebulizer |
| WO2011160932A1 (en) | 2010-06-24 | 2011-12-29 | Boehringer Ingelheim International Gmbh | Nebulizer |
| CN103096897A (zh) * | 2010-07-16 | 2013-05-08 | 希普拉有限公司 | 包含r(+)布地奈德和一种或多种支气管扩张剂的药物组合物 |
| RU2578975C2 (ru) * | 2010-08-03 | 2016-03-27 | КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. | Фармацевтический препарат, содержащий ингибитор фосфодиэстеразы |
| EP2618818A4 (en) * | 2010-09-22 | 2014-10-29 | Map Pharmaceuticals Inc | CORTICOSTEROID PARTICLES AND METHOD FOR PRODUCING THE SAME |
| US20120204871A1 (en) | 2011-02-10 | 2012-08-16 | Julio Cesar Vega | Stable, non-corrosive formulations for pressurized metered dose inhalers |
| TWI399202B (zh) * | 2011-03-17 | 2013-06-21 | Intech Biopharm Ltd | 製備用於治療呼吸道疾病之定量噴霧吸入劑的製程方法 |
| EP2694220B1 (de) | 2011-04-01 | 2020-05-06 | Boehringer Ingelheim International GmbH | Medizinisches gerät mit behälter |
| US9827384B2 (en) | 2011-05-23 | 2017-11-28 | Boehringer Ingelheim International Gmbh | Nebulizer |
| BR112014003907A2 (pt) | 2011-08-19 | 2017-06-13 | Intech Biopharm Ltd. | método para preparar inalador pulverizado de dose medida para tratar doença respiratória |
| WO2013152894A1 (de) | 2012-04-13 | 2013-10-17 | Boehringer Ingelheim International Gmbh | Zerstäuber mit kodiermitteln |
| JP6643231B2 (ja) | 2013-08-09 | 2020-02-12 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | ネブライザ |
| ES2836977T3 (es) | 2013-08-09 | 2021-06-28 | Boehringer Ingelheim Int | Nebulizador |
| GB201321717D0 (en) | 2013-12-09 | 2014-01-22 | Pharmachemie Bv | Inhalable Medicaments |
| GB201321712D0 (en) | 2013-12-09 | 2014-01-22 | Pharmachemie Bv | Dry Powder Inhaler |
| WO2015169430A1 (en) | 2014-05-07 | 2015-11-12 | Boehringer Ingelheim International Gmbh | Nebulizer |
| IL247927B (en) | 2014-05-07 | 2022-09-01 | Boehringer Ingelheim Int | Container, a device that turns a liquid into a fine spray and use |
| CN116036425A (zh) | 2014-05-07 | 2023-05-02 | 勃林格殷格翰国际有限公司 | 喷雾器、指示器装置及容器 |
| US20170189329A1 (en) * | 2014-07-29 | 2017-07-06 | 3M Innovative Properties Company | Method of preparing a pharmaceutical composition |
| ES2796177T5 (es) | 2015-12-04 | 2024-10-29 | Mexichem Fluor Sa De Cv | Composición farmacéutica |
| CN106581010B (zh) * | 2016-12-28 | 2019-03-05 | 四川普锐特医药科技有限责任公司 | 一种气溶胶制剂及定量吸入气雾剂 |
| US11344562B2 (en) | 2017-08-15 | 2022-05-31 | Nephron Pharmaceuticals Corporation | Aqueous nebulization composition |
| EP3807889A1 (en) | 2018-06-14 | 2021-04-21 | AstraZeneca UK Limited | Methods for treating and preventing symptoms of asthma with a corticosteroid pharmaceutical composition |
| JP7402631B2 (ja) | 2018-08-27 | 2023-12-21 | 帝人株式会社 | 極細炭素繊維混合物、その製造方法、及び炭素系導電助剤 |
| CN109464429B (zh) * | 2018-12-13 | 2021-04-27 | 上海方予健康医药科技有限公司 | 一种吸入压力定量气雾剂药物组合物及其制备方法 |
| CN112137957B (zh) | 2019-06-26 | 2022-07-29 | 长风药业股份有限公司 | 一种药用吸入气雾剂及其制备方法 |
| CN112972384B (zh) * | 2019-12-02 | 2022-03-18 | 长风药业股份有限公司 | 一种格隆溴铵和茚达特罗原料药微粉混合物的制备方法 |
| CN117357485B (zh) * | 2023-11-01 | 2024-09-24 | 山东京卫制药有限公司 | 一种改良的可吸入的载体颗粒及应用 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6123924A (en) * | 1991-09-25 | 2000-09-26 | Fisons Plc | Pressurized aerosol inhalation compositions |
| NZ244439A (en) * | 1991-09-25 | 1994-01-26 | Fisons Plc | Pressurised aerosol compositions comprising hydrofluoroalkane, dispersed |
| DK0613371T3 (da) * | 1991-12-18 | 2002-05-13 | Astrazeneca Ab | Ny kombination af formoterol og budesonid |
| DE19536902A1 (de) * | 1995-10-04 | 1997-04-10 | Boehringer Ingelheim Int | Vorrichtung zur Hochdruckerzeugung in einem Fluid in Miniaturausführung |
| SE9603669D0 (sv) | 1996-10-08 | 1996-10-08 | Astra Ab | New combination |
| WO1998021175A1 (en) | 1996-11-11 | 1998-05-22 | Sepracor, Inc. | Process for the preparation of optically pure isomers of formoterol |
| SE9703407D0 (sv) * | 1997-09-19 | 1997-09-19 | Astra Ab | New use |
| US6309623B1 (en) * | 1997-09-29 | 2001-10-30 | Inhale Therapeutic Systems, Inc. | Stabilized preparations for use in metered dose inhalers |
| SE9802073D0 (sv) * | 1998-06-11 | 1998-06-11 | Astra Ab | New use |
| ES2234266T3 (es) | 1998-07-24 | 2005-06-16 | Jago Research Ag | Formulaciones medicas para aerosoles. |
| US6004537A (en) | 1998-12-18 | 1999-12-21 | Baker Norton Pharmaceuticals, Inc. | Pharmaceutical solution aerosol formulations containing fluoroalkanes, budesonide and formoterol |
| SE9900834D0 (sv) | 1999-03-09 | 1999-03-09 | Astra Ab | Novel combination |
| PE20011227A1 (es) * | 2000-04-17 | 2002-01-07 | Chiesi Farma Spa | Formulaciones farmaceuticas para inhaladores de polvo seco en la forma de aglomerados duros |
| GB0009584D0 (en) | 2000-04-18 | 2000-06-07 | Glaxo Group Ltd | Pharmaceutical compositions |
| GB0012260D0 (en) * | 2000-05-19 | 2000-07-12 | Astrazeneca Ab | Novel composition |
| GB0016876D0 (en) * | 2000-07-11 | 2000-08-30 | Astrazeneca Ab | Novel formulation |
| US20030018019A1 (en) * | 2001-06-23 | 2003-01-23 | Boehringer Ingelheim Pharma Kg | Pharmaceutical compositions based on anticholinergics, corticosteroids and betamimetics |
| SE0200312D0 (sv) * | 2002-02-01 | 2002-02-01 | Astrazeneca Ab | Novel composition |
-
2002
- 2002-02-01 SE SE0200312A patent/SE0200312D0/xx unknown
-
2003
- 2003-01-29 AT AT08166881T patent/ATE463241T1/de active
- 2003-01-29 EP EP03703575A patent/EP1474117B1/en not_active Revoked
- 2003-01-29 ES ES08166881T patent/ES2342509T3/es not_active Expired - Lifetime
- 2003-01-29 AT AT03703575T patent/ATE423552T1/de active
- 2003-01-29 EP EP08166881A patent/EP2036549B1/en not_active Expired - Lifetime
- 2003-01-29 BR BR0307193-6A patent/BR0307193A/pt not_active Application Discontinuation
- 2003-01-29 WO PCT/SE2003/000156 patent/WO2003063842A1/en not_active Ceased
- 2003-01-29 PL PL372118A patent/PL211836B1/pl unknown
- 2003-01-29 UA UA20040806416A patent/UA79445C2/uk unknown
- 2003-01-29 DE DE60326320T patent/DE60326320D1/de not_active Expired - Lifetime
- 2003-01-29 PT PT03703575T patent/PT1474117E/pt unknown
- 2003-01-29 KR KR1020047011787A patent/KR100947168B1/ko not_active Expired - Lifetime
- 2003-01-29 RU RU2004122921/15A patent/RU2301673C2/ru active
- 2003-01-29 SI SI200331805T patent/SI2036549T1/sl unknown
- 2003-01-29 DK DK03703575T patent/DK1474117T3/da active
- 2003-01-29 US US10/502,685 patent/US7759328B2/en not_active Expired - Lifetime
- 2003-01-29 CN CNB038031221A patent/CN1287774C/zh not_active Expired - Lifetime
- 2003-01-29 DE DE60332067T patent/DE60332067D1/de not_active Expired - Lifetime
- 2003-01-29 JP JP2003563536A patent/JP2005521663A/ja not_active Withdrawn
- 2003-01-29 AU AU2003206289A patent/AU2003206289B2/en not_active Expired
- 2003-01-29 KR KR1020097024298A patent/KR20090125857A/ko not_active Ceased
- 2003-01-29 CA CA2474479A patent/CA2474479C/en not_active Expired - Lifetime
- 2003-01-29 ES ES03703575T patent/ES2321180T3/es not_active Expired - Lifetime
- 2003-01-29 SI SI200331563T patent/SI1474117T1/sl unknown
- 2003-01-29 NZ NZ534452A patent/NZ534452A/en not_active IP Right Cessation
- 2003-01-29 PT PT08166881T patent/PT2036549E/pt unknown
- 2003-01-29 DK DK08166881.6T patent/DK2036549T3/da active
-
2004
- 2004-07-21 IS IS7360A patent/IS7360A/is unknown
- 2004-07-22 IL IL163160A patent/IL163160A/en active IP Right Grant
- 2004-07-27 CO CO04071996A patent/CO5611098A2/es not_active Application Discontinuation
- 2004-07-28 MX MXPA04007295A patent/MXPA04007295A/es active IP Right Grant
- 2004-07-29 ZA ZA2004/06086A patent/ZA200406086B/en unknown
- 2004-08-19 NO NO20043458A patent/NO337006B1/no not_active IP Right Cessation
-
2009
- 2009-04-29 CY CY20091100471T patent/CY1109030T1/el unknown
-
2010
- 2010-02-26 JP JP2010041992A patent/JP5259636B2/ja not_active Expired - Lifetime
- 2010-05-28 US US12/790,196 patent/US8143239B2/en not_active Expired - Fee Related
- 2010-06-14 CY CY20101100546T patent/CY1110081T1/el unknown
-
2012
- 2012-03-05 US US13/411,939 patent/US8575137B2/en not_active Expired - Fee Related
-
2013
- 2013-04-16 IS IS9028A patent/IS2960B/is unknown
- 2013-10-18 US US14/057,548 patent/US20140286878A1/en not_active Abandoned
-
2015
- 2015-03-02 US US14/635,550 patent/US20160022703A1/en not_active Abandoned
-
2017
- 2017-02-08 US US15/427,425 patent/US10166247B2/en not_active Expired - Lifetime
-
2018
- 2018-08-22 US US16/108,368 patent/US20190216828A1/en not_active Abandoned
-
2020
- 2020-03-27 US US16/832,590 patent/US11311558B2/en not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005521663A5 (https=) | ||
| US8226983B2 (en) | Method for producing pulverized organic compound particle | |
| JP3549197B2 (ja) | ユビキノン含有製剤 | |
| RU2535017C2 (ru) | Композитный порошок из органического вещества для применения в медицине, способ его получения и его суспензия | |
| EP2623498A1 (en) | Sodium salt of 6-fluoro-3-hydroxy-2-pyrazine carboxamide | |
| EP2902014B1 (en) | Process for producing solid particles | |
| JP2016138114A (ja) | 鼻および眼へのコルチコステロイド水溶液送達 | |
| CN112516291B (zh) | 含人白蛋白的制剂及其制备方法 | |
| BR112021008197A2 (pt) | suspensão de edaravone para administração oral | |
| BR112019016118A2 (pt) | forma farmacêutica de dosagem de suspensão oral de lamotrigina | |
| Pomázi et al. | Analysis of co-spray-dried meloxicam–mannitol systems containing crystalline microcomposites | |
| BR112018074532B1 (pt) | Composição farmacêutica, aerossol, e, kit. | |
| KR102912349B1 (ko) | 눈의 상황을 치료하기 위한 제제 | |
| CN100376251C (zh) | 含有甲基维生素b12的冻干制剂及其制备方法 | |
| US20250221975A1 (en) | Pharmaceutical composition and preparation method therefor | |
| JP7589393B2 (ja) | 滅菌処理したヘテロシクリデンアセトアミド誘導体含有懸濁液 | |
| CN109806249A (zh) | 类胡萝卜素在制备激活tmem16a离子通道的产品中的应用、激活剂、试剂盒和药物 | |
| PT1944028E (pt) | Formas orais sólidas de ebastina | |
| Kamat et al. | Formulation development of small and large volume injections | |
| JP7589394B2 (ja) | ヘテロシクリデンアセトアミド誘導体を含む配合剤 | |
| JP5161528B2 (ja) | パクリタキセル微粒子、パクリタキセル微粒子分散液、および、これらの製造方法 | |
| WO2025220042A1 (en) | Pharmaceutical compositions comprising asundexian and use thereof | |
| WO2014054005A2 (es) | PREPARACIÓN NANOSOMAL DEL COMPLEJO FORMADO POR QUERCETINA (U OTRO FLAVONOL, FLAVONA O UN DERIVADO DE LOS MISMOS) Y LA 2-HYDROXIPROPIL- β-CICLODEXTRINA PARA USO INTRAVENOSO EN PATOLOGÍA CEREBRAL | |
| Magi et al. | Engineering a nifurtimox nanosuspension: toward improved pharmaceutical attributes | |
| WO2025126240A1 (en) | Pharmaceutical compositions and use thereof |